Know Cancer

forgot password

Development and Implementation of a Cancer Fatigue Education Program

18 Years
80 Years
Not Enrolling
Patient With Histologically Confirmed Malignancy

Thank you

Trial Information

Development and Implementation of a Cancer Fatigue Education Program

Inclusion Criteria:

- - Age> 18 years.

- Patient with histologically confirmed malignancy, during initial treatment with
chemotherapy, followed or not by surgery, or the first week of radiotherapy. Patients
with hematologic malignancy (including non-Hodgkin's lymphoma or Hodgkin's disease)
may be included in the study, except for patients with leukemia.

- Having a fatigue up during the week preceding the inclusion level measured by the
average patient with 2 or more on a visual analogue scale (VAS) graded from 0 to 10
(0 expressing no fatigue and 10 the maximum fatigue imaginable ).

- Volunteered to participate in PEPs "Coping with fatigue."

- Usually followed as outpatients.

- Condition preserved (ECOG PS 2).

- Available for all meetings of the educational program (5 sessions of 2 hours over a
period of 5 weeks).

- Able to read, write and understand French.

- Resident (s) in a 50 km radius around the center investigator.

- Can be contacted by phone.

- Compulsory membership of a social security system.

- Obtaining informed consent in writing, signed and dated.

Exclusion Criteria:

- - Patient (e) with the inclusion anemia with a hemoglobin level below 10 g/100 mL.

- Patient (e) having a documented history of cognitive or psychiatric disorders.

- Patient (e) can not be followed for family, social, geographical or psychological.

- Patient (e) deprived of their liberty by court or administrative

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Education program

Outcome Description:

The main indicator of patient satisfaction after the education program will be the change during 8 weeks of follow-up in the mean fatigue score measured on a specific scale (FACT-F) (32).

Outcome Time Frame:

8 weeks

Safety Issue:


Principal Investigator

Franck CHAUVIN, Pr

Investigator Role:

Principal Investigator

Investigator Affiliation:

Institut de Cancérologie de la Loire


French: Direction Générale de la Santé

Study ID:




Start Date:

May 2007

Completion Date:

June 2010

Related Keywords:

  • Patient With Histologically Confirmed Malignancy
  • cancer
  • fatigue program education
  • Neoplasms
  • Fatigue